Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:741 (5 April), doi:10.1136/bmj.39535.642025.DB
Melissa Sweet
1 Sydney
| The first 150 words of the full text of this article appear below. |
Senior academics are outraged that the University of Queensland has asked an academic to apologise to a drug company for his public comments on a vaccine against human papillomavirus that was developed jointly by the university and the company.
Academics at the university and elsewhere say that the request is a threat to academic freedom and warn that it raises worrying concerns about universities independence and ability to negotiate conflicts of interest.
The request came after the company, CSL, wrote to the universitys vice chancellor complaining about comments on the radio made by Andrew Gunn, a senior lecturer in general practice.
The programme dealt with the general issue of pharmaceutical marketing and briefly mentioned Gardasil, whose development has reaped millions of dollars for the university as well as public and political kudos.
CSLs director of public affairs, Rachel David, wrote: "I feel Dr Gunns comments are inappropriate and inconsistent with
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
What can you learn from this BMJ paper? Read Leanne Tite's Paper+